News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

Sign In

Breath-based VOC analysis could give clinical labs a faster, noninvasive way to assess gut microbiome health and detect disease earlier.

Researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia have identified a potential rapid, noninvasive method for assessing gut microbiome health using breath analysis.

The research was published in Cell Metabolism and reported by The Scientist, a sibling brand of Dark Daily.

For clinical laboratory professionals, the approach highlights a possible shift away from time-intensive stool-based sequencing toward faster, more scalable testing workflows. “One of the key barriers to integrating our knowledge of the microbiome into clinical care is the time it takes to analyze the data on the microbiome,” said Ariel Hernandez-Leyva, an MD/PhD student working for gut microbiome researcher Andrew Kau’s group at Washington University School of Medicine. (Photo credit: Kau Lab)

Breath-Based Testing Could Streamline Microbiome Workflows

The research team found that volatile organic compounds (VOCs) in breath samples closely correlate with gut microbiome activity, suggesting a streamlined alternative that could reduce turnaround times and expand access to microbiome-informed diagnostics. In both human and mouse studies, breath “volatilome” profiles mirrored microbial metabolites in the gut.

In a proof-of-concept analysis, VOC patterns distinguished children with asthma from healthy controls and predicted levels of a gut bacterial species associated with the condition. Such capabilities could support earlier clinical decision-making and reduce reliance on complex sequencing workflows.

If validated in larger studies, breath-based diagnostics could offer clinical labs a practical pathway to integrate microbiome insights into routine testing, with potential applications in pediatric care, infectious disease risk assessment, and chronic disease management.

This article was created with the assistance of Generative AI and has undergone editorial review before publishing.

—Janette Wider

;